Each ml contains 10mg Maropitant citrate.
Marovet is a neurokinin-1 (NK1) receptor antagonist that binds to substance P within the emetic centre. Substance P is the key neurotransmitter involved in the vomiting process.
Cats: Indicated for the prevention and treatment of vomiting, as well as the reduction of nausea.
Dogs: Indicated for the prevention and treatment of vomiting, chemotherapy-induced nausea and vomiting, perioperative nausea and vomiting, and to improve recovery from general anaesthesia following the use of μ-opioid receptor agonists such as morphine.
Maropitant is not recommended for the treatment of motion sickness. Supportive measures—such as dietary control, fluid therapy, and addressing underlying causes—should be implemented alongside this antiemetic.
Cats/Dogs: 1 mg/kg (1 ml/10 kg) subcutaneously (SC) or intravenously (IV) for up to five consecutive days. IV administration should be given as a single bolus without mixing with any other fluids.
To prevent vomiting, administer one hour before the event. The clinical effect is expected to last approximately 24 hours.
As maropitant accumulates in the body after once-daily repeated administration, lower doses than recommended may be sufficient in some animals and for subsequent doses.
